Cargando…
Targeted therapy in gastric cancer
BACKGROUND: Gastric cancer is the fourth most common cancer worldwide. Surgery in combination with multimodal therapy provides the only curative therapy until now. The importance of targeted therapy became clear over the last few years. Due to the implication of HER2 and angiogenesis-directed target...
Autores principales: | Jomrich, G., Schoppmann, S. F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065582/ https://www.ncbi.nlm.nih.gov/pubmed/27795701 http://dx.doi.org/10.1007/s10353-016-0389-1 |
Ejemplares similares
-
Comparison of Inflammation-Based Prognostic Scores in a Cohort of Patients with Resectable Esophageal Cancer
por: Jomrich, G., et al.
Publicado: (2017) -
Effect of electrical stimulation therapy of the lower esophageal sphincter in GERD patients with ineffective esophageal motility
por: Paireder, Matthias, et al.
Publicado: (2020) -
Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity
por: Paireder, Matthias, et al.
Publicado: (2020) -
Viennese risk prediction score for Advanced Gastroesophageal carcinoma based on Alarm Symptoms (VAGAS score): characterisation of alarm symptoms in advanced gastro-oesophageal cancer and its correlation with outcome
por: Puhr, Hannah Christina, et al.
Publicado: (2020) -
External validation of the NUn score for predicting anastomotic leakage after oesophageal resection
por: Paireder, Matthias, et al.
Publicado: (2017)